VPAC2 KO cells had a slight in vivo growth delay as compared to wild-type cells (Supplementary Fig. 2g) and improved survival (Supplementary Fig. 2h), suggesting possible indirect effects on tumor growth impacted by VIP signaling through the VPAC2 receptor in the Panc02 cell line. This evidence concerns the gene VIP and neoplasm.